NCT07089043View on ClinicalTrials.gov

A Study in Subjects With Neurogenic Orthostatic Hypotension

PHASE2RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 12, 2025

Primary Completion Date

November 21, 2025

Study Completion Date

December 31, 2025

Conditions
Neurogenic Orthostatic Hypotension
Interventions
DRUG

CST-3056

Administered as an oral solution

DRUG

Placebo

Administered as an oral solution

Trial Locations (3)

10019

RECRUITING

CuraSen Investigational Site, New York

37240

RECRUITING

CuraSen Investigational Site, Nashville

07724

RECRUITING

CuraSen Investigational Site, Eatontown

Sponsors
All Listed Sponsors
lead

CuraSen Therapeutics, Inc.

INDUSTRY

NCT07089043 - A Study in Subjects With Neurogenic Orthostatic Hypotension | Biotech Hunter | Biotech Hunter